Cargando…

Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients

BACKGROUND: Sarcoidosis is a granulomatous systemic inflammatory disease in which more than 90 % of all patients develop pulmonary manifestations. Several gene associations have previously been described, but established and clinically useful biomarkers are still absent. This study aimed to find pro...

Descripción completa

Detalles Bibliográficos
Autores principales: Hamsten, Carl, Wiklundh, Emil, Grönlund, Hans, Schwenk, Jochen M., Uhlén, Mathias, Eklund, Anders, Nilsson, Peter, Grunewald, Johan, Häggmark-Månberg, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893268/
https://www.ncbi.nlm.nih.gov/pubmed/27259755
http://dx.doi.org/10.1186/s12931-016-0381-0
_version_ 1782435524233920512
author Hamsten, Carl
Wiklundh, Emil
Grönlund, Hans
Schwenk, Jochen M.
Uhlén, Mathias
Eklund, Anders
Nilsson, Peter
Grunewald, Johan
Häggmark-Månberg, Anna
author_facet Hamsten, Carl
Wiklundh, Emil
Grönlund, Hans
Schwenk, Jochen M.
Uhlén, Mathias
Eklund, Anders
Nilsson, Peter
Grunewald, Johan
Häggmark-Månberg, Anna
author_sort Hamsten, Carl
collection PubMed
description BACKGROUND: Sarcoidosis is a granulomatous systemic inflammatory disease in which more than 90 % of all patients develop pulmonary manifestations. Several gene associations have previously been described, but established and clinically useful biomarkers are still absent. This study aimed to find proteins in bronchoalveolar lavage (BAL) fluid that can be associated with the disease. METHODS: We developed and performed profiling of 94 selected proteins in BAL fluid and serum samples obtained from newly diagnosed and non-treated patients with sarcoidosis. Using multiplexed immunoassays, a total of 317 BAL and 217 serum samples were analyzed, including asthmatic patients and healthy individuals as controls. RESULTS: Our analyses revealed increased levels of eight proteins in sarcoidosis patients compared to controls. Out of these, fibronectin (FN1) and C-C motif chemokine 2 (CCL2) revealed the strongest associations. In addition, cadherin 5 (CDH5) was found to correlate positively with lymphocyte cell numbers in BAL fluid. CONCLUSIONS: Applying a high throughput proteomics screening technique, we found proteins of potential clinical relevance in the context of sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-016-0381-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4893268
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48932682016-06-05 Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients Hamsten, Carl Wiklundh, Emil Grönlund, Hans Schwenk, Jochen M. Uhlén, Mathias Eklund, Anders Nilsson, Peter Grunewald, Johan Häggmark-Månberg, Anna Respir Res Research BACKGROUND: Sarcoidosis is a granulomatous systemic inflammatory disease in which more than 90 % of all patients develop pulmonary manifestations. Several gene associations have previously been described, but established and clinically useful biomarkers are still absent. This study aimed to find proteins in bronchoalveolar lavage (BAL) fluid that can be associated with the disease. METHODS: We developed and performed profiling of 94 selected proteins in BAL fluid and serum samples obtained from newly diagnosed and non-treated patients with sarcoidosis. Using multiplexed immunoassays, a total of 317 BAL and 217 serum samples were analyzed, including asthmatic patients and healthy individuals as controls. RESULTS: Our analyses revealed increased levels of eight proteins in sarcoidosis patients compared to controls. Out of these, fibronectin (FN1) and C-C motif chemokine 2 (CCL2) revealed the strongest associations. In addition, cadherin 5 (CDH5) was found to correlate positively with lymphocyte cell numbers in BAL fluid. CONCLUSIONS: Applying a high throughput proteomics screening technique, we found proteins of potential clinical relevance in the context of sarcoidosis. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12931-016-0381-0) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-04 2016 /pmc/articles/PMC4893268/ /pubmed/27259755 http://dx.doi.org/10.1186/s12931-016-0381-0 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hamsten, Carl
Wiklundh, Emil
Grönlund, Hans
Schwenk, Jochen M.
Uhlén, Mathias
Eklund, Anders
Nilsson, Peter
Grunewald, Johan
Häggmark-Månberg, Anna
Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
title Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
title_full Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
title_fullStr Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
title_full_unstemmed Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
title_short Elevated levels of FN1 and CCL2 in bronchoalveolar lavage fluid from sarcoidosis patients
title_sort elevated levels of fn1 and ccl2 in bronchoalveolar lavage fluid from sarcoidosis patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4893268/
https://www.ncbi.nlm.nih.gov/pubmed/27259755
http://dx.doi.org/10.1186/s12931-016-0381-0
work_keys_str_mv AT hamstencarl elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT wiklundhemil elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT gronlundhans elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT schwenkjochenm elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT uhlenmathias elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT eklundanders elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT nilssonpeter elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT grunewaldjohan elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients
AT haggmarkmanberganna elevatedlevelsoffn1andccl2inbronchoalveolarlavagefluidfromsarcoidosispatients